Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - INTEREST INCOME & EXPENSE
Interest Income & Expense RARE - Ultragenyx Pharmaceutical Inc.
66 M
LAST VALUE
49.78%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR